Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Severe asthma].

Pascal Chanez1, Sally Wenzel

  • 1Département des maladies respiratoires, AP-HM, Université de la Méditerranée, F-13009 Marseille, France. chanez@montp.inserm.fr

Presse Medicale (Paris, France : 1983)
|December 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Ex Vivo Model of Post Infectious Bronchiolitis Obliterans in Children Using Reconstituted Human Bronchial Epithelium.

Biomolecules·2026
Same author

Predicting Clinical Response to Benralizumab Using CT Imaging: Prognostic BenraliScan Study.

Chest·2026
Same author

Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity.

Allergy·2026
Same author

Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial.

The Lancet. Respiratory medicine·2025
Same author

Reframing remission in severe asthma: a conceptual framework for distinguishing disease activity versus damage.

The Lancet. Respiratory medicine·2025
Same author

CD146: a promising target in respiratory diseases.

European respiratory review : an official journal of the European Respiratory Society·2025
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Diagnosing severe asthma requires careful reevaluation and physician follow-up. Identifying phenotypes is key to understanding mechanisms and guiding effective treatments for better asthma control.

Area of Science:

  • Pulmonology
  • Allergy and Immunology
  • Clinical Medicine

Context:

  • Severe asthma is defined as difficult-to-control asthma refractory to standard management.
  • Diagnosis requires thorough reevaluation, including objective tests and consideration of influencing factors.

Purpose:

  • To outline diagnostic criteria and follow-up recommendations for severe asthma.
  • To emphasize the importance of phenotype identification in severe asthma.

Summary:

  • Diagnosis involves reassessing management, performing respiratory function tests, and evaluating environmental, comorbid, and adherence factors.
  • Follow-up necessitates objective criteria, including quality of life questionnaires, pulmonary function, airway inflammation assessment, and exacerbation/healthcare use monitoring.

Related Experiment Videos

Impact:

  • Phenotyping severe asthma enhances understanding of mechanisms, prognosis, and treatment selection.
  • This approach aims to improve patient outcomes and guide novel therapeutic development.